Minidiab

Known as: Mindiab, Minidab, Minodiab 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Glipizide is an effective antidiabetic agent, however, it suffers from relatively short biological half-life. To solve this… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Objective: To compare curative effect and safety of two kinds of suifonylureas in elderly type 2 diabetics.Methods: Sixty… (More)
Is this relevant?
2008
2008
Objective To observe the effect of combined Minidiab and fluvastatin in 2 type diabetes merging abnormal blood fat.Methods 120… (More)
Is this relevant?
2005
2005
To study the effect of mindiab on peripheral neropathy. Methods: Type 2 diabetics rats were induced by diets enriched sucrose and… (More)
Is this relevant?
1994
1994
The levels of glucose, insulin, and C-peptide in the blood serum were measured in 38 subjects with normal and impaired glucose… (More)
Is this relevant?
1994
1994
The authors have examined the effects of sulfonylurea drugs glibenclamide and glipizide and of their analogs manilil and minidiab… (More)
Is this relevant?
1993
1993
Analysis of the effects of glurenorm and some sulfonylurea drugs, such as maninil, minidiab, chlorpropamide, on some parameters… (More)
Is this relevant?
1988
1988
The hypoglycemic action of Minidiab (Glipizide) and maninil (Glibenclamide) were studied in an acute experiment. 10 patients with… (More)
Is this relevant?